Jaguar Health (JAGX) Deferred Taxes (2017)
Jaguar Health (JAGX) posted quarterly Deferred Taxes of -$990549.0 for Q4 2017.
Jaguar Health (JAGX) Deferred Taxes (2017) Analysis & Trends
Jaguar Health (JAGX) has reported Deferred Taxes for 1 consecutive years, with -$990549.0 the latest figure, recorded in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.91 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 64.87 Bn | 59.68 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.18 Bn | 53.04 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.96 Bn | 36.87 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.23 Bn | 992.69 Mn | 2.66 Mn |
| 7 | BioNTech SE | 27.79 Bn | 9.40 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.37 Bn | 26.53 Bn | - | - |
| 10 | Jaguar Health | 446,569.26 | -9.62 Mn | 19.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -990,549.00 |